Category

News

Tabula Rasa HealthCare’s Risk Adjustment Division Launches New Online Training for Physicians and Other Providers

Moorestown, NJ, June 29, 2020 — Tabula Rasa HealthCare ®(TRHC) (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, has launched the “Clinical Documentation Excellence” (CDE) Online Education series for Medicare risk adjustment. The program is designed for physicians, physician assistants, nurse practitioners, and other clinicians who offer services in value-based care settings, including Programs of All-inclusive Care for the Elderly (PACE), Medicare Advantage, managed Medicaid, and Accountable Care Organizations. “Optimizing risk adjustment... Read More

Tabula Rasa HealthCare® Expands Clinical Services for Patients Enrolled in Medicare Advantage

Moorestown, NJ, June 25, 2020 – Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, announced it is expanding its clinical services to include special needs and high-risk patient populations enrolled in Medicare Advantage. TRHC will assist health plans in meeting the Care for Older Adults (COA) program requirements. Starting with a large multi-state health plan, TRHC’s SinfoniaRx® solution will begin providing medication reviews and pain assessments... Read More

TRHC and Equiscript Launch an Advanced Medication Adherence Reporting and Analytics Program

Moorestown, NJ, JUNE 16, 2020 – Tabula Rasa HealthCare® Corporation (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety has partnered with Equiscript, a 340B patient pharmacy care and technology company, to deliver advanced medication adherence reports and analytics for Equiscript and its community health center and hospital clients. “A Medication Safety Review™ is the most important step in setting a patient’s foundation for an optimized medication regimen,” said TRHC Chairman and... Read More

Regence and TRHC Partner on COVID-19 Virtual Clinical Trial to Assess Proposed Treatment Risks

Moorestown, NJ, June 9, 2020 – Regence and Tabula Rasa HealthCare® (NASDAQ: TRHC) announced today that the companies have partnered on a virtual clinical trial to assess the risk of adverse drug events (ADEs) associated with drugs repurposed for the treatment of COVID-19. The trial examines de-identified medical information for approximately 500,000 Regence health plan members across multiple lines of business. Regence is a family of health plans in Oregon, Idaho, Utah and select counties... Read More

A Message from Tabula Rasa HealthCare

June 5, 2020 Recently, we have seen the overwhelming pain and hurt wrapped in those heart-wrenching cries for help: ‘I can’t breathe. Please stop. I can’t breathe.’ Systemic racism is another ‘virus’ that we must address. George Floyd, Ahmaud Arbery, and Breonna Taylor are just three names in a span of generations of untimely and unjust deaths. As we witnessed the heartbreak across America, especially in our communities of color, we will not pretend to... Read More

TRHC’s MedWise Risk Score™ Reduces the Odds of Adverse Drug Events, Keeping Patients Safer

Moorestown, NJ, May 27, 2020 – Tabula Rasa HealthCare® (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, announces the journal Pharmacy has published its research article “Association of a Novel Medication Risk Score with Adverse Drug Events and Other Pertinent Outcomes Among Participants of the Programs of All-Inclusive Care for the Elderly”. The research article is a 12-month analysis of medical claims data of 1,965 Program of All-Inclusive Care for the... Read More

TRHC Fills the Information Gap on COVID-19 Proposed Therapies with a New Digital Resource

Moorestown, NJ, May 19, 2020 – Tabula Rasa HealthCare® Corporation (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today published on the web the TRHC COVID-19 Treatment and Therapy Digital Resource. Developed by TRHC’s Precision Pharmacotherapy Research & Development Institute, the resource provides a comprehensive analysis and clinical reviews of potential treatments and therapies for COVID-19. “There are knowledge gaps surrounding the proposed treatments for COVID-19,” said TRHC Chairman and CEO... Read More

TRHC and ASCP Sign Letter of Intent to offer MedWise™ to Consultant Pharmacists

Moorestown, NJ, May 11, 2020 – Tabula Rasa HealthCare®, Inc. (TRHC) (Nasdaq: TRHC), a healthcare technology company advancing the field of medication safety, today announces it has signed a Letter of Intent with ASCP, a membership association that represents pharmacists, healthcare professionals and students serving the unique medication needs of older adults. The first of its kind, the strategic collaboration will jointly offer TRHC’s medication safety software, MedWise™, available to the pharmacist membership of ASCP.... Read More

Tabula Rasa HealthCare Reports First Quarter 2020 Results

MOORESTOWN, N.J., May 07, 2020 – Tabula Rasa HealthCare®, Inc. (“TRHC”) (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, today reported financial results for the first quarter ended March 31, 2020. First Quarter 2020 Highlights Total revenue of $72.8 million, near the high end of our guidance range of $68.5 million to $73.5 million for the first quarter of 2020, increased 19%, on a reported basis, and 9%, on an organic basis,... Read More

TRHC and Speed Script Expand Partnership for Clinical Documentation

  Moorestown, NJ, May 4, 2020 – Tabula Rasa HealthCare®, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today announced that Speed Script®, a Kansas-based pharmacy management system and services provider, has selected TRHC’s PrescribeWellness™ as its preferred eCare solution provider. “Speed Script is happy to expand our partnership with TRHC,” said Speed Script Executive Vice President/Chief Technology Officer Chuck Welch. “Working with TRHC to create an integrated solution... Read More
1 2 3 18